Yeni nesil oral antikoagülanlar ile warfarin kullanan hastaların kanama komplikasyonu açısından karşılaştırılması: Beş yıllık inceleme
Comparison of new oral anticoagulants and warfarin in patients in terms of bleeding complication: A five-year review
- Tez No: 654382
- Danışmanlar: PROF. DR. ÖZGÜR SÖĞÜT
- Tez Türü: Tıpta Uzmanlık
- Konular: Sağlık Eğitimi, İlk ve Acil Yardım, Health Education, Emergency and First Aid
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 2021
- Dil: Türkçe
- Üniversite: Sağlık Bilimleri Üniversitesi
- Enstitü: İstanbul Haseki Eğitim ve Araştırma Hastanesi
- Ana Bilim Dalı: Acil Tıp Ana Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: 48
Özet
Aim The aim of this retrospective study to analyze bleeding complications in patients admitted to the emergency department using oral anticoagulants and compare the rates of major or minor bleeding complications between NOAC and warfarin. Materials and Methods Among a total of 24,774 patients were examined who admitted to the emergency department between 01.01.2015 and 31.12.2019 with a diagnosis of non-traumatic bleeding. A total of 453 patients were included in the study who developed bleeding complications: 99 patients used NOAC and 354 patients used warfarin. Patients with major or minor bleeding due to NOAC and warfarin use were compared in terms of age, gender, comorbid diseases, bleeding type, and clinical outcome. Results In our study, we found 453 patients who developed bleeding complications: 354 patients used warfarin and 99 patients used NOAC. When the frequency of minor bleeding complications and gender were examined, there was no statistically significant difference between the groups using warfarin or NOAC. On the other hand, the mean age was found to be significantly higher in patients who developed minor bleeding due to NOAC use compared to patients who developed minor bleeding due to warfarin use. When the frequency of major bleeding complications and gender were examined, there was no statistically significant difference between the groups using warfarin or NOAC. On the other hand, the mean age was found to be significantly higher in patients who developed major bleeding due to NOAC use compared to patients who developed minor bleeding due to warfarin use. vii While there was no significant difference between patients using warfarin or NOAC in terms of major and fatal intracranial bleeding complication rates, relatively nonfatal gastrointestinal bleeding was observed to be significantly increased in the NOAC group compared to the warfarin group. Conclusion According to our data, although it has some differences all major and all minor bleeding complications in patients using NOAC have a similar bleeding rate compared to patients using warfarin. While warfarin has less risk than NOACs in terms of major and relatively non-fatal gastrointestinal bleeding, it can be said that it has a similar risk in terms of major and fatal intracranial bleeding. Keywords Bleeding complication, warfarin, NOAC
Özet (Çeviri)
Aim The aim of this retrospective study to analyze bleeding complications in patients admitted to the emergency department using oral anticoagulants and compare the rates of major or minor bleeding complications between NOAC and warfarin. Materials and Methods Among a total of 24,774 patients were examined who admitted to the emergency department between 01.01.2015 and 31.12.2019 with a diagnosis of non-traumatic bleeding. A total of 453 patients were included in the study who developed bleeding complications: 99 patients used NOAC and 354 patients used warfarin. Patients with major or minor bleeding due to NOAC and warfarin use were compared in terms of age, gender, comorbid diseases, bleeding type, and clinical outcome. Results In our study, we found 453 patients who developed bleeding complications: 354 patients used warfarin and 99 patients used NOAC. When the frequency of minor bleeding complications and gender were examined, there was no statistically significant difference between the groups using warfarin or NOAC. On the other hand, the mean age was found to be significantly higher in patients who developed minor bleeding due to NOAC use compared to patients who developed minor bleeding due to warfarin use. When the frequency of major bleeding complications and gender were examined, there was no statistically significant difference between the groups using warfarin or NOAC. On the other hand, the mean age was found to be significantly higher in patients who developed major bleeding due to NOAC use compared to patients who developed minor bleeding due to warfarin use. vii While there was no significant difference between patients using warfarin or NOAC in terms of major and fatal intracranial bleeding complication rates, relatively nonfatal gastrointestinal bleeding was observed to be significantly increased in the NOAC group compared to the warfarin group. Conclusion According to our data, although it has some differences all major and all minor bleeding complications in patients using NOAC have a similar bleeding rate compared to patients using warfarin. While warfarin has less risk than NOACs in terms of major and relatively non-fatal gastrointestinal bleeding, it can be said that it has a similar risk in terms of major and fatal intracranial bleeding. Keywords Bleeding complication, warfarin, NOAC
Benzer Tezler
- Yeni nesil oral antikoagülanların diş çekimi sonrası kanama üzerine etkilerinin karşılaştırılması
The comparasion between effects of new types of oral anticoagulants on bleeding after tooth extraction
MEHMET ÇALIŞKAN
Diş Hekimliği Uzmanlık
Türkçe
2017
Diş HekimliğiÇukurova ÜniversitesiAğız Diş ve Çene Cerrahisi Ana Bilim Dalı
DOÇ. DR. MEHMET EMRE BENLİDAYI
- Yeni oral antikoagülan kullanmakta iken serebrovasküler olay (iskemik veya hemorajik) geçiren ve nöroloji kliniğine yatırılan hastaların epidemiyolojik incelemesi ve serebrovasküler olay oranının araştırılması
Başlık çevirisi yok
BETÜL ÖZENÇ
Tıpta Uzmanlık
Türkçe
2019
NörolojiSağlık Bilimleri ÜniversitesiNöroloji Ana Bilim Dalı
DOÇ. DR. OĞUZHAN KURŞUN
- Non-varisiyel üst gastrointestinal sistem kanaması tanısıyla yatan hastaların antikoagülan ve proton pompa inhibitörü kullanımlarının ve klinik seyirlerinin incelenmesi
Evaluation of use of anticoagulants and clinical courses of hospitalized patients diagnosed with non-variceal upper gastrointestinal bleeding
BRUSK FERHAT TANHAN
Tıpta Uzmanlık
Türkçe
2021
GastroenterolojiSağlık Bilimleri Üniversitesiİç Hastalıkları Ana Bilim Dalı
PROF. DR. LEVENT FİLİK
- Malignite ve varis dışı üst gastrointestinal sistem kanamalı hastalarda yeni nesil oral antikoagülan kullanım sıklığı ve prognoza etkisinin değerlendirilmesi
Evaluation of the frequency and their effects on prognosis of use new generation oral anticoagulants in patients with non-malignancy and non-variceal upper gastrointestinal system bleeding
MAHSUM OZAN
Tıpta Uzmanlık
Türkçe
2023
İç HastalıklarıSağlık Bilimleri Üniversitesiİç Hastalıkları Ana Bilim Dalı
DOÇ. DR. İHSAN SOLMAZ
- Atriyal fibrilasyon bilgi ölçeğinin geliştirilmesi
Development of atrial fibrillation knowledge scale
HÜLYA AKBULUT
Yüksek Lisans
Türkçe
2022
HemşirelikDokuz Eylül ÜniversitesiHemşirelik Ana Bilim Dalı
PROF. DR. HATİCE MERT